Janux Therapeutics, Inc. (JANX)
NGM – Real Time Price. Currency in USD
16.75
+0.23 (1.39%)
Market open: Aug 12, 2026, 11:30 AM EDT
16.52
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
16.75
+0.23 (1.39%)
Market open: Aug 12, 2026, 11:30 AM EDT
16.52
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $27.8M significantly exceed its total debt $21.0M, ensuring strong financial flexibility
Total current assets $983.3M exceed Total current liabilities $60.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 16.35 | 6.05 | 10 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 9M | 8M | 11M | 10M | 24M |
| Gross Profit | 8M | 6M | 9M | 8M | 12M |
| Operating Income | -67M | -73M | -99M | -158M | -144M |
| Net Income | -63M | -58M | -69M | -114M | -103M |
| EBITDA | -66M | -71M | -97M | -156M | -110M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -33.04 | -25.21 | 1.0 |
| Next quarter | N/A | -7.81 | 1.0 |
| Current year | 193.03 | 5.28 | 7.5 |
| Next year | -78.88 | -54.82 | 1.0 |
| Weighted average score | 2.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 175.03 | 9.81 | 10.26 | 55.98 | 8.3 |
| Y/Y | 999 | 35.11 | 36.36 | 27.51 | 10 |
| 3y average | 6.44 | -25.15 | -8.91 | -26.31 | 2.0 |
| 5y average | 231.02 | -110 | -9.02 | -113.77 | 3.3 |
| Weighted average score | 5.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |